연구성과로 돌아가기
JCR 2023 저널 목록 (777 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SYDNEY LAW REVIEW | SYDNEY LAW SCH | 0082-0512 | 1444-9528 | ESCI | LAW | 368 | 0.7 | Q2 | 40.1 | 59.9 | 173/430 | 0.8 | Q2 | 0.6 | 0.1 | 0.82 | 156/430 | Q2 | 63.84 | 0.000 | 0.071 | 0.356 | Q2 | 14 | 100.0% | 12.9 | 6.0 | 14 | 0.0% | 2025-03-24 17:22:32 | 바로가기 |
| Transcription-Austin | TAYLOR & FRANCIS INC | 2154-1264 | 2154-1272 | ESCI | BIOCHEMISTRY & MOLECULAR BIOLOGY | 714 | 3.6 | Q2 | 40.1 | 59.9 | 126/313 | 3.5 | Q2 | 3.4 | 0.8 | 0.50 | 229/313 | Q3 | 27.00 | 0.001 | 0.251 | 1.644 | Q1 | 11 | 9.1% | 6.6 | 7.0 | 1 | 45.7% | 2025-03-24 16:55:57 | 바로가기 |
| Transformations in Business & Economics | VILNIUS UNIV | 1648-4460 | N/A | SSCI | ECONOMICS | 839 | 1.8 | Q2 | 40.1 | 59.9 | 241/600 | 1.2 | Q3 | 1.7 | 0.1 | 0.37 | 369/603 | Q3 | 38.89 | 0.001 | 0.146 | 0.170 | Q4 | 87 | 98.8% | 3.7 | 5.2 | 86 | 0.0% | 2025-03-24 17:05:07 | 바로가기 |
| Tuberculosis | CHURCHILL LIVINGSTONE | 1472-9792 | 1873-281X | SCIE | RESPIRATORY SYSTEM | 3,433 | 2.8 | Q2 | 40.1 | 59.9 | 41/101 | 2.6 | Q3 | 2.6 | 0.5 | 0.48 | 64/101 | Q3 | 37.13 | 0.003 | 0.558 | 0.629 | Q3 | 96 | 91.7% | 7.8 | 8.9 | 88 | 21.4% | 2025-03-24 18:09:45 | 바로가기 |
| UNIVERSITY OF TORONTO LAW JOURNAL | UNIV TORONTO PRESS INC | 0042-0220 | 1710-1174 | SSCI | LAW | 472 | 0.7 | Q2 | 40.1 | 59.9 | 173/430 | 0.9 | Q2 | 0.6 | 0.1 | 0.72 | 178/430 | Q2 | 58.72 | 0.001 | 0.140 | 0.539 | Q2 | 28 | 96.4% | 12.8 | 14.5 | 27 | 0.0% | 2025-03-24 17:22:29 | 바로가기 |
| Utrecht Law Review | UTRECHT UNIV LIBRARY OPEN ACCESS JOURNALS | 1871-515X | 1871-515X | ESCI | LAW | 283 | 0.7 | Q2 | 40.1 | 59.9 | 173/430 | 1.2 | Q2 | 0.7 | <0.1 | 0.71 | 183/430 | Q2 | 57.56 | 0.000 | 0.067 | 0.379 | Q2 | 17 | 100.0% | 9.0 | 10.5 | 17 | 100.0% | 2025-03-24 17:22:34 | 바로가기 |
| WISCONSIN LAW REVIEW | UNIV WISCONSIN LAW SCHOOL | 0043-650X | 1943-1120 | SSCI | LAW | 703 | 0.7 | Q2 | 40.1 | 59.9 | 173/430 | 0.8 | Q2 | 0.5 | 0.6 | 0.80 | 161/430 | Q2 | 62.67 | 0.001 | 0.144 | 0.407 | Q2 | 42 | 100.0% | 14.9 | 10.1 | 42 | 0.0% | 2025-03-24 17:22:26 | 바로가기 |
| World Competition | KLUWER LAW INT | 1011-4548 | 1875-8436 | ESCI | LAW | 201 | 0.7 | Q2 | 40.1 | 59.9 | 173/430 | 0.7 | Q2 | 0.5 | 0.3 | 0.80 | 161/430 | Q2 | 62.67 | 0.000 | 0.056 | 0.304 | Q2 | 17 | 100.0% | 8.6 | 9.9 | 17 | 0.0% | 2025-03-24 17:22:38 | 바로가기 |
| AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE | TAYLOR & FRANCIS INC | 0095-2990 | 1097-9891 | SCIE, SSCI | SUBSTANCE ABUSE | 3,371 | 2.7 | Q2 | 40.2 | 59.8 | 23/56 | 3.6 | Q1 | 2.6 | 0.5 | 0.80 | 24/56 | Q2 | 58.04 | 0.004 | 0.820 | 1.253 | Q1 | 71 | 93.0% | 7.1 | 7.3 | 66 | 7.2% | 2025-03-24 18:12:40 | 바로가기 |
| Annals of Gastroenterological Surgery | WILEY-V C H VERLAG GMBH | 2475-0328 | 2475-0328 | SCIE | GASTROENTEROLOGY & HEPATOLOGY | 1,661 | 2.9 | Q2 | 40.2 | 59.8 | 58/143 | 3.6 | Q2 | 2.6 | 0.4 | 0.53 | 74/143 | Q3 | 48.60 | 0.003 | 0.760 | 0.978 | Q2 | 98 | 80.6% | 3.5 | 6.4 | 79 | 72.0% | 2025-03-24 17:15:02 | 바로가기 |
| Brazilian Journal of Otorhinolaryngology | ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL | 1808-8694 | 1808-8686 | SCIE | OTORHINOLARYNGOLOGY | 2,650 | 1.7 | Q2 | 40.2 | 59.8 | 27/66 | 1.8 | Q2 | 1.6 | 0.3 | 1.22 | 13/66 | Q1 | 81.06 | 0.002 | 0.481 | 0.440 | Q3 | 126 | 81.8% | 7.2 | 8.7 | 103 | 97.5% | 2025-03-24 17:35:09 | 바로가기 |
| CLINICAL OTOLARYNGOLOGY | WILEY | 1749-4478 | 1749-4486 | SCIE | OTORHINOLARYNGOLOGY | 4,317 | 1.7 | Q2 | 40.2 | 59.8 | 27/66 | 2.2 | Q2 | 1.6 | 0.3 | 0.88 | 26/66 | Q2 | 61.36 | 0.003 | 0.722 | 0.615 | Q2 | 97 | 67.0% | 8.7 | 8.1 | 65 | 18.0% | 2025-03-24 17:35:08 | 바로가기 |
| Clinics in Liver Disease | W B SAUNDERS CO-ELSEVIER INC | 1089-3261 | 1557-8224 | SCIE | GASTROENTEROLOGY & HEPATOLOGY | 3,041 | 2.9 | Q2 | 40.2 | 59.8 | 58/143 | 4.2 | Q1 | 2.9 | 0.7 | 0.61 | 66/143 | Q2 | 54.20 | 0.003 | 0.589 | 1.209 | Q1 | 65 | 98.5% | 7.5 | 6.8 | 64 | 2.8% | 2025-03-24 17:14:59 | 바로가기 |
| Colorectal Disease | WILEY | 1462-8910 | 1463-1318 | SCIE | GASTROENTEROLOGY & HEPATOLOGY | 8,126 | 2.9 | Q2 | 40.2 | 59.8 | 58/143 | 3.1 | Q2 | 2.6 | 0.5 | 0.97 | 32/143 | Q1 | 77.97 | 0.008 | 1.793 | 0.953 | Q2 | 191 | 89.0% | 7.6 | 7.3 | 170 | 31.2% | 2025-03-24 17:14:56 | 바로가기 |
| Feminist Africa | AFRICAN GENDER INST | 1726-4596 | 1726-4596 | ESCI | WOMENS STUDIES | 169 | 1.5 | Q2 | 40.2 | 59.8 | 27/66 | 1.6 | Q3 | 1.4 | 0.1 | 0.30 | 44/66 | Q3 | 34.09 | 0.000 | 0.011 | 0.384 | Q4 | 11 | 100.0% | 9.8 | 8.0 | 11 | 0.0% | 2025-03-24 18:16:05 | 바로가기 |
페이지 이동: